Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.

Orazio Fortunato,Veronica Huber,Miriam Segale,Agata Cova,Viviana Vallacchi,Paola Squarcina,Licia Rivoltini,Paola Suatoni,Gabriella Sozzi,Ugo Pastorino,Mattia Boeri

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology（2022）

引用 0|浏览6

暂无评分

摘要

Implementing LDCT screening trials with minimally invasive blood tests could help reduce unnecessary procedures and optimize cost-effectiveness.

查看译文

关键词

lung cancer screening,lung cancer,biomarker,blood-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要